Clinical Trials in Phoenix

Showing 1661-1680 of 7,960 trials

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

NCT06829667

This study is intended to be a retrospective chart review of patients with chronic ankle instability who have undergone a lateral ligament reconstructive procedure for ATFL repair (isolated or non-isolated) with suture tape augmentation. Patients that have been treated at any of the participating institutions that have undergone an ATFL reconstruction with Arthrex InternalBrace augmentation who have postoperative hospital or ASC records of safety and effectiveness as measured by adverse events, potential complications, and potential functional outcomes past the 10-week time point will be included.

Lateral Ankle Instability

Stryker Trauma and Extremities75 participantsStarted Oct 2023

Phoenix, Arizona, United States • Kansas City, Kansas, United States • Ocean City, New Jersey, United States +1 more locations

COMPLETEDPhase 2< 1 mile

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

NCT05113953

The primary objective of this study is to assess the efficacy of 2 doses of centanafadine sustained-release (SR) (200 milligrams \[mg\] and 400 mg total daily dose \[TDD\]) compared with placebo in adults with moderate to severe binge eating disorder (BED).

Binge-Eating Disorder

Otsuka Pharmaceutical Development & Commercialization, Inc.147 participantsStarted Dec 2021

Phoenix, Arizona, United States • Beverly Hills, California, United States • Encino, California, United States +22 more locations

Retrospective Study of Suture Tape for Soft Tissue Reconstruction in Patients Suffering From Lateral Ankle Instability

A Trial of Centanafadine Efficacy, Safety, and Tolerability in Adult Subjects With Binge Eating Disorder

Find Trials by Condition in Phoenix

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

A Study of Nemtabrutinib (MK-1026) in Participants With Relapsed or Refractory Hematologic Malignancies (ARQ 531-101/MK-1026-001)

Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants With Primary Biliary Cholangitis (PBC) With Inadequate Response to Ursodeoxycholic Acid (UDCA) and/or Obeticholic Acid (OCA) Treatment.

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer

Nivolumab in Treating Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

OCS DCD Heart + CAP Continued Follow-Up

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

FebriDx® Method Comparison Study Protocol

A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungoides or Sezary Syndrome and Treated With Standard of Care Mogamulizumab

Study to Evaluate the Efficacy & Safety of the INTERCEPT Blood System for RBCs in Complex Cardiac Surgery Patients

Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus

A Study of LM-24C5 For Advanced Solid Tumors

Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children

OCS-01 in Treating Inflammation and Pain in Post-cataract Patients

Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis

Skin Reactions Related to Thoracic Implantable Chamber Dressings